| 1 |
Unified Parkinson's Disease Rating Scale
(1610 times)
|
Neurology
(908 times)
|
PD (1112 times)
DBS (161 times)
STN (156 times)
|
1990 L-deprenyl therapy in Thai patients with Parkinson's disease: before and after, clinical trial of 50 patients.
|
| 2 |
Unified PD Rating Scale
(149 times)
|
Neurology
(85 times)
|
PD (133 times)
DBS (15 times)
STN (14 times)
|
1997 The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
|
| 3 |
Unified Parkinson's Disease Score -III
(1 time)
|
Chemistry
(1 time)
|
CSF (1 time)
DA (1 time)
DOPAC (1 time)
|
2017 Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment.
|
| 4 |
United Kingdom Parkinson Disease Society
(1 time)
|
Complementary Therapies
(1 time)
|
ESS (1 time)
H-Y (1 time)
LED (1 time)
|
2013 [Clinical characteristics in Parkinson's disease patients with cognitive impairment and effects of cognitive impairment on sleep].
|
| 5 |
universal parkinsonism disease rate scale
(1 time)
|
Pharmacology
(1 time)
|
---
|
2005 [Estimating the potential of antioxidant therapy for patients with Parkinson's disease diagnosis].
|
| 6 |
UPDRS III off
(1 time)
|
Neurology
(1 time)
|
DBS (1 time)
QOL (1 time)
STN (1 time)
|
2011 Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
|
A Search Service for Abbreviation / Long Form